Several different assays for PD-L1 expression are available, all of which involve the scoring of immunohistochemically stained tumor sections by trained pathologists, but differences in antibodies used, cell types assessed, scoring systems, and cutoffs, as well as inter-observer variability, suggest that assay results may not be concordant [17]. This evidence concerns the gene CD274 and neoplasm.